EDITORIAL

Tort reform: Federal impetus for change
Otolaryngologists have been active in helping to assure that patients have access to expert care. It is essential that we remain familiar with changes in the healthcare delivery system so we can have input as new regulations evolve, and so we can adapt to changing programs. It is also important that we recognize not only the shortcomings of legislature proposals, but also the strengths.
Many of us have had reservations about the Patient Protection and Aff ordable Care Act (PPACA), passed into law in March 2010 (and currently subject to court challenges). However, many people agree that it contained some good provisions. Most physicians support the notion that our nation's population should have access to healthcare (although we diff er in opinion as to how that aim should be achieved); most of us agree that eliminating the preexisting condition problem is good; and most of us are in favor of allowing children to remain covered under their parents' policy beyond graduation from college. However, many people are not aware that the law also addresses, at least to a modest degree, malpractice costs. It established a $50 million demonstration program that allows states to experiment with alternatives to the current process for managing medical liability; $50 million is a small amount in a legislation that will probably end up costing more than $1 trillion, but at least it is something.
Under the PPACA, the Department of Health and Human Services is empowered to award grants to states, enabling them to establish and assess new approaches to dispute resolution and tort litigation. Th ese experimental programs must attempt to improve access to prompt and fair resolution of disputes, improve access to liability insurance, improve patient safety, and encourage disclosure of medical errors. Creating this program suggests that the lawmakers who were in control of the legislature when the law was enacted recognize the need to do something about the malpractice problem, even though they have consistently opposed caps on noneconomic damages as a solution. Although the success of caps in Texas and California does not seem to convince these legislators that caps are a good approach, it is encouraging to know that at least some eff ort to address the problem was funded in the new law.
It is also interesting to note that the Obama administration has provided additional grants within its medical liability reform and patient safety initiative. In June 2010, the administration awarded nearly $20 million for seven demonstration grants, six of which focused on patient safety. Although that initiative is admirable, it does not address the needed tort reform directly. New York State received $3 million for the only grant that tested a new approach to handling malpractice claims (a negotiation program directed by a judge). Encouragingly, the administration also provided an additional $3.5 million for planning grants to support the development of projects to reform medical liability.
Data from the American Medical Association (AMA) confi rm that the malpractice crisis is still with us. According to an article written by Carol K. Kane and published on the AMA Web site, approximately 65% of malpractice claims fi led against phy-
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The XprESS™ Multi-Sinus Dilation Tool is as easy to use as a sinus seeker. For use in treating frontal, sphenoid and maxillary sinuses, XprESS provides ENTs with a single tool for treating multiple sinuses. The tool consists of a curved sinus seeker outfitted with a slideable dilation balloon and malleable tip that can be reshaped to the patient's anatomy. sicians are dismissed or withdrawn without payment, and 90% of malpractice cases that go to trial result in verdicts in favor of the physician (no negligence). 1 Th e article goes on to say, "Average defense costs per claim were $40,649, ranging from a low of $22,163 among claims that were dropped, dismissed or withdrawn, to a high of over $100,000 for tried cases. " 1 Th ese numbers are put into greater perspective in light of additional AMA data showing that an average of 95 medical malpractice claims are fi led for every 100 physicians in the United States. 2 Several states have already initiated eff orts to address this perplexing problem. Th ey will not be reviewed in detail in this editorial. However, one approach requires further thought and debate within the scientifi c community in general, and specifi cally among otolaryngologists; and it may even warrant prospective action. In the state of Oregon, a project was started that focuses on the use of clinical practice guidelines to establish the legal standard of care. Th e PPACA has advocated use of evidence-based research. Th e Oregon-proposed law would theoretically support that initiative by legislating that a physician who used best practice guidelines would be able to use the practice guideline as a defense if he were sued for an alleged problem arising from that care.
Th is concept sounds good. Th e problem is that the vast majority of what we do is not evidence based. Hence, even when we make a good-faith eff ort to develop valid guidelines, we depend on opinion in many cases because high-quality evidence does not exist. Ideally, the opinions are expert and well vetted, but even with the best of intentions that is not always the case. Nevertheless, I predict that we will be called upon more and more to develop clinical guidelines and practice parameters, not only to improve medical care and to satisfy third-party carriers, but probably also to help minimize our liability. If that prediction is correct, it is important for us to waste no time in developing the best guidelines and practice parameters we can for most care rendered by otolaryngologists.
Th e process of guideline development brings into sharp focus our defi ciencies in evidence-based data. Th e process should be used to provide appropriate disclaimers in the practice guidelines, acknowledg-ing components that are based on opinion rather than high-level evidence. It should also be used to identify and prioritize research that is needed to develop evidence on which revised guidelines may be based. Funding sources should be encouraged to support such projects, and our legislators should be approached about creating new sources of federal funding specifically to support evidence-based research initiated to address scientifi c defi ciencies identifi ed in the process of developing practice guidelines.
I do not believe that addressing these issues will provide adequate tort reform. Th e $250,000 caps on noneconomic damages passed in Texas and California have demonstrated that such caps are eff ective; and we should continue to support legislative initiatives to establish caps. However, it would also be wise for us to become familiar with other approaches to reforming the liability process, and especially to establish quickly a substantial number of well-considered guidelines for care of otolaryngologic disorders, as well as prospective research projects to improve our body of evidencebased research.
